Get reliable answers to your questions at Westonci.ca, where our knowledgeable community is always ready to help. Our Q&A platform provides quick and trustworthy answers to your questions from experienced professionals in different areas of expertise. Explore comprehensive solutions to your questions from knowledgeable professionals across various fields on our platform.
Sagot :
Neurodegenerative disorders like Alzheimer's disease and Parkinson's disease are characterized by the progressive atrophy and loss of neuronal function.
- Lack of knowledge of the essential molecular pathways that cause neurodegeneration is one of the major barriers to the development of neuroprotective medicines for Parkinson's disease and other neurodegenerative illnesses.
- A deeper understanding of the diseases' molecular processes is urgently required.
- The lack of suitable in vitro models is a significant barrier to the creation of innovative neuroprotective therapies and the identification of early illness biomarkers.
- Furthermore, the majority of the ones that are available do not have active neuron-glia interactions. However, it is generally known that astrocytes are essential to both a healthy brain and to pathology, therefore their absence affects the applicability of these models.
Learn more about the neurodegenration with the help of the given link:
https://brainly.com/question/13047924
#SPJ4
We hope this was helpful. Please come back whenever you need more information or answers to your queries. Thank you for choosing our platform. We're dedicated to providing the best answers for all your questions. Visit us again. Get the answers you need at Westonci.ca. Stay informed by returning for our latest expert advice.
